The effect of Chlamydophila pneumoniae Major Outer Membrane Protein (MOMP) on macrophage and T cell-mediated immune responses

Immunobiology
Alexandra Bermudez-FajardoErnesto Oviedo-Orta

Abstract

The Major Outer Membrane Protein (MOMP) belongs to the membrane complex of cysteine-rich proteins of Chlamydophila pneumoniae. Although MOMP can elicit strong immune responses it fails to confer long-term protection against infection in animal models. This effect has been attributed, at least in part, to an inadequate induction of protective Th1-mediated immune responses. In an effort to understand the cellular mechanisms associated to the immunomodulatory properties of MOMP we studied the effect of this protein on mouse macrophages and naïve T-lymphocytes. We found that incubation of mouse macrophages with recombinant MOMP (rMOMP) results in an increased secretion of MMP-9 and a down-regulation of MHC class II, CD86 and CD40. This was accompanied by an increase in IL-10 and IFNγ but not in IL-12 secretion. rMOMP induced a down-regulation of the expression of CD69 and CD154 markers by activated CD4(+) T cells, and enhanced the secretion of IL-2 and IL-10 by these cells. Conversely, rMOMP-treated macrophages up-regulated the expression of CD69 but not CD154, inhibited the synthesis of IL-10 and up-regulated the production of IFNγ by activated CD8(+) T cells. Immunization of mice with MOMP induced the synthesis only of MOMP-speci...Continue Reading

References

Jan 1, 1980·Annual Review of Microbiology·J Schachter, H D Caldwell
Sep 1, 1993·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·M R EkmanP Saikku
Jan 1, 1993·Scandinavian Journal of Rheumatology·J T GranA H Andreassen
Nov 1, 1995·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·M E Ward
Dec 31, 1997·British Journal of Rheumatology·I Machtey
Sep 7, 1999·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·J K Chia, L Y Chia
Mar 29, 2000·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·S AirenneA Laurila
Jun 6, 2000·The Journal of Infectious Diseases·K OuchiT Nakazawa
Jun 6, 2000·The Journal of Infectious Diseases·R C BrunhamG M McClarty
Nov 18, 2000·Infection and Immunity·S HalmeH M Surcel
Jan 12, 2001·The European Respiratory Journal·M R Hammerschlag
Aug 22, 2002·International Reviews of Immunology·Giovanni RicevutiChristian J Wiedermann
Sep 27, 2002·European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery·E PetersenK A Angquist
Nov 28, 2002·Clinical and Experimental Immunology·L BandholtzM E Rottenberg
Sep 18, 2003·FEMS Immunology and Medical Microbiology·Jürgen RödelEberhard Straube
Nov 25, 2003·Journal of Veterinary Medicine. B, Infectious Diseases and Veterinary Public Health·L E HoelzleM M Wittenbrink
Apr 16, 2004·The European Respiratory Journal·J GieffersM Maass
Dec 21, 2005·Revue neurologique·C Boschin-CrinquetteL Defebvre
Mar 18, 2006·Clinics in Chest Medicine·Richard J Martin
May 4, 2006·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·B A Cunha
Jun 15, 2006·Journal of Medical Microbiology·Hideaki IkejimaYoshimasa Yamamoto
Jan 24, 2007·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Swati Kumar, Margaret R Hammerschlag
Mar 14, 2008·Clinical Science·Caroline Watson, Nicholas J Alp

❮ Previous
Next ❯

Related Concepts

Related Feeds

Babesiosis

Babesiosis is caused by parasites of the genus babesia, which are transmitted in nature by the bite of an infected tick. Discover the latest research on babesiosis here.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.